Valuation: North China Pharmaceutical Company.Ltd

Market Cap 8.36B 1.24B 1.07B 1B 921M 1.74B 118B 1.76B 11.81B 4.62B 58.85B 4.65B 4.55B 195B P/E 2024
69.9x
P/E 2025 51.7x
Enterprise Value 18.03B 2.67B 2.32B 2.16B 1.99B 3.76B 254B 3.8B 25.49B 9.97B 127B 10.03B 9.81B 421B EV / Sales 2024
1.89x
EV / Sales 2025 2.07x
Free-Float
40.58%
Yield 2024
0.58%
Yield 2025 0.63%
1 day+0.21%
1 week+2.31%
Current month+1.04%
1 month+6.10%
3 months-6.53%
6 months-13.19%
Current year-11.93%
1 week 4.77
Extreme 4.77
4.94
1 month 4.41
Extreme 4.41
5.08
Current year 4.11
Extreme 4.11
6.07
1 year 4.11
Extreme 4.11
7.12
3 years 3.83
Extreme 3.83
7.46
5 years 3.83
Extreme 3.83
13.45
10 years 3.83
Extreme 3.83
20.24
Manager TitleAgeSince
Chief Executive Officer 55 28/11/2025
Director of Finance/CFO 46 10/04/2024
Investor Relations Contact 45 -
Director TitleAgeSince
Chairman 49 22/03/2016
Director/Board Member 53 23/04/2021
Director/Board Member 54 12/10/2022
Date Insider Type Main position Quantity % Market Cap.
2/25/25 A Buy

Chairman

1,600 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+0.21%+2.31%-29.32%-16.18% 1.23B
-0.51%-8.60%+45.08%+148.21% 1T
+0.20%-4.42%+49.05%+50.81% 613B
-0.53%-7.37%+23.64%+65.03% 433B
+0.48%-2.77%+40.27%+34.96% 350B
+0.08%-4.45%+31.74%+39.89% 292B
+2.09%-9.27%+5.42%+7.61% 239B
+1.75%-8.29%-1.73%-42.05% 206B
+2.94%-0.78%+29.17%+60.32% 204B
+3.13%+0.69%+18.11%+71.90% 163B
Average +1.08%-3.99%+21.14%+42.05% 350.17B
Weighted average by Cap. +0.72%-5.58%+33.86%+70.99%

Financials

2024 2025
Net sales 9.87B 1.46B 1.27B 1.18B 1.09B 2.06B 139B 2.08B 13.95B 5.46B 69.52B 5.49B 5.37B 230B 9.24B 1.37B 1.19B 1.11B 1.02B 1.93B 130B 1.95B 13.07B 5.11B 65.1B 5.14B 5.03B 216B
Net income 127M 18.81M 16.33M 15.23M 13.99M 26.46M 1.79B 26.75M 180M 70.19M 895M 70.64M 69.1M 2.96B 183M 27.12M 23.55M 21.95M 20.17M 38.14M 2.58B 38.56M 259M 101M 1.29B 102M 99.6M 4.27B
Net Debt 9.79B 1.45B 1.26B 1.17B 1.08B 2.04B 138B 2.06B 13.84B 5.41B 68.96B 5.45B 5.33B 228B 9.67B 1.43B 1.24B 1.16B 1.07B 2.02B 136B 2.04B 13.68B 5.35B 68.14B 5.38B 5.26B 226B
Logo North China Pharmaceutical Company.Ltd
North China Pharmaceutical Co Ltd is a China-based company primarily engaged in the research, development, production and sales of pharmaceutical products. The Company's main products include anti-infective drugs, nephrology and immunomodulatory drugs, biotechnology drugs, cardiovascular and cerebrovascular and immunomodulatory agents, vitamins and health consumer products, nervous and blood system drugs, pharmaceutical intermediates, anti-epidemic drugs, pesticides and Veterinary drugs. The Company is also engaged in pharmaceutical and other logistics trade pharmaceuticals. The Company's products are mainly used in chemical pharmaceuticals, modern biotechnology drugs, vitamins and health consumer products, bioagricultural and veterinary drugs and other fields. The Company mainly conducts its businesses in domestic and overseas markets.
Employees
9,972
Date Price Change Volume
04/08/26 CN¥4.870 +0.21% 13,001,631
03/08/26 CN¥4.860 +0.83% 11,758,319
31/07/26 CN¥4.820 -0.21% 15,092,125
30/07/26 CN¥4.830 +0.63% 16,376,019
29/07/26 CN¥4.800 +0.84% 15,225,700

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600812 Stock